Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

EMD Serono wins approval for drug to treat rare form of skin cancer

By , Globe Staff

It’s the first cancer treatment from the Rockland arm of Germany’s Merck KGaA.

Burlington biotech Flexion could be sold to Sanofi

By , Globe Staff

Company’s stock price skyrockets on a report that it’s negotiating with the French drug maker.

Biogen wins patent ruling for its $4 billion MS treatment

By , Globe Staff

Shares of Biogen were trading up 1.5 percent after the Cambridge biotech’s patent was upheld in court.

Biopharma facing stiffer opposition

By , Globe Staff

The backlash against steep drug prices has become a rare subject of bipartisan agreement in Washington, D.C.